Proscia

Proscia leads the digital pathology revolution with their Concentriq® platform suite, combining AI-powered diagnostics with streamlined workflows. Their solutions help pathology labs transition from traditional microscopes to efficient digital systems, significantly improving diagnostic speed and accuracy.

Proscia tackles critical pain points like fragmented data management, workflow inefficiencies, and diagnostic accuracy. Their integrated platforms streamline operations, enhance quality control, and provide powerful tools for both clinical diagnostics and research applications. 

Proscia recently enhanced their Concentriq AP platform with advanced AI capabilities, earning recognition from CB Insights as one of the most promising digital health companies. These improvements reflect their commitment to advancing diagnostic capabilities in pathology. 

Proscia's digital pathology solutions eliminate data silos and reduce turnaround times in diagnostic workflows. Their Concentriq platforms enable pathologists to analyze tissue samples digitally, collaborate remotely, and leverage AI insights for more precise diagnoses. 

Proscia serves leading healthcare institutions, from major biopharma companies to academic hospitals like Uppsala University Hospital. Their solutions cater to pathologists, lab directors, and data scientists working in anatomic pathology and research settings. 

The magic lies in Proscia's unique blend of cutting-edge AI technology and deep pathology expertise. Their leadership team, including co-founders David West and Nathan Buchbinder, combines innovation with practical industry knowledge to revolutionize diagnostic workflows.